Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VI-0609 vs BiCNU in BEAM Conditioning for Lymphoma AHCT
NCT06915246Phase 2Recruiting
- Sponsor
- VIVUS
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VI-0609 in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by VIVUS. Started Mar 2025; status: recruiting.
02
Drugs
VI-0609
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT06915246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06915246.